台股 » 個股 » 威剛 » 個股(權證)/期貨 » 個股權證

威剛

(3260)
可現股當沖
  • 股價
    400.0
  • 漲跌
    ▲2.5
  • 漲幅
    +0.63%
  • 成交量
    33,018
  • 產業
    上櫃 半導體類股
  • 1171人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     

威剛 (3260) 個股權證

威剛 (3260) 個股權證-認購
權證代號價格漲跌漲跌幅買價賣價成交量成交
波動
買價
波動
賣價
波動
買賣
價差
履約價行使
比例
價內外程度實質
槓桿
剩餘
天數
威剛國票61購01 700126 9.75 ▼-1.75 -15.22% 9.61200.00%0.00%0.00%0.25%227.390.052 價平 -74.81% 0 256
威剛元大55購01 700163 16.7 -- -- 14.9000.00%0.10%0.00%0.00%221.10.084 價內 80.91% 0 11
威剛元大56購01 700164 12.9 -- -- 11.6000.00%81.72%0.00%0.00%224.970.066 價內 77.8% 0 40
威剛群益56購02 700377 12.9 ▲2.95 +29.65% 7000.00%0.00%0.00%0.00%241.90.072 價平 -64.324% 0 46
威剛國泰55購01 700460 22.4 -- -- 2022.400.00%0.00%0.00%0.12%203.20.103 價平 -95.62% 0 19
威剛凱基56購01 700472 22.3 -- -- 19.4000.00%0.00%0.00%0.00%241.90.124 價平 -64.324% 0 50
威剛永豐56購02 700516 20.2 -- -- 1824.100.00%0.00%0.00%0.34%203.930.093 價平 -94.92% 0 53
威剛國票55購02 700583 17.5 -- -- 15.116.100.00%0.00%0.00%0.07%251.580.103 價平 -58.001% 0 22
威剛國泰55購02 700602 19.5 -- -- 1717.600.00%0.00%0.00%0.04%232.230.103 價平 -71.167% 0 22
威剛凱基56購02 700610 28 -- -- 0000.00%0.00%0.00%0.00%222.550.114 價平 -78.612% 0 53
威剛群益55購05 700727 13 -- -- 9.55000.00%0.00%0.00%0.00%264.640.083 價平 -50.204% 0 26
威剛凱基55購02 700751 17 ▲0.1 +.59% 12.9000.00%0.00%0.00%0.00%272.870.103 價平 -45.674% 0 27
威剛統一5C購03 700756 2.58 ▼-0.29 -10.1% 2.582.8200.00%0.00%0.00%0.09%236.810.014 價平 -67.856% 0 242
威剛國泰55購03 700761 16.5 -- -- 14.114.700.00%0.00%0.00%0.04%261.260.103 價平 -52.147% 0 27
威剛永豐5A購01 700786 9.1 -- -- 8.1000.00%0.00%0.00%0.00%273.590.049 價平 -45.29% 0 180
威剛中信57購02 700791 9 ▲1.45 +19.21% 6.65800.00%0.00%0.00%0.20%261.260.047 價平 -52.147% 0 88
威剛群益57購02 700820 12.7 ▲1.6 +14.41% 9.5514.100.00%0.00%0.00%0.48%272.870.072 價平 -45.674% 0 89
威剛永豐64購01 700828 8.9 -- -- 8.99.500.00%0.00%0.00%0.07%272.870.041 價平 -45.674% 0 363
威剛元大54購23 700950 9.25 -- -- 7.95000.00%0.10%0.00%0.00%257.390.057 價內 54.43% 0 4
威剛旗下保健食品通路商立萬利今起遭列處置 20分鐘撮合一盤Anue鉅亨-2026/03/18
威剛1月獲利大暴衝 EPS 11.09元逼近去年第四季Anue鉅亨-2026/03/17
〈威剛法說〉存貨300億元提前達陣 下半年NAND從小缺變大缺Anue鉅亨-2026/03/05
威剛 相關文章